Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "R05DB" (16)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Pentoxyverine (R05DB05) 1 products
WHO-DDD
IP
CI
Bisolvon Pentoxyverin
2.13 mg/ml
200 ml
k.A.
Sirup: Pentoxyverini Hydrogenocitras 2.13 mg/ml
Opella Healthcare
Switzerland AG
D
FB
G
Butamirate (R05DB13) 6 products
WHO-DDD
IP
CI
Bexin Hustenstiller
Butamirat
200 ml
k.A.
Sirup: Butamirati Dihydrogenocitras 1.5 mg/ml/ml
Spirig HealthCare AG
D
FB
G
IP
CI
NeoCitran Hustenstiller
200 ml
k.A.
Sirup: Butamirati Dihydrogenocitras 15mg / 10ml
Haleon Schweiz AG
D
FB
G
IP
CI
Triofan Antitussif
200 ml
k.A.
Sirup: Butamirati Dihydrogenocitras 15mg / 10ml
VERFORA SA
D
FB
G
IP
CI
NeoCitran Hustenstiller
20 ml
k.A.
Drops: Butamirati Dihydrogenocitras 5 mg/ml
Haleon Schweiz AG
D
FB
G
IP
CI
Triofan Antitussif
30 ml
k.A.
Drops: Butamirati Dihydrogenocitras 22.5 mg/ml
VERFORA SA
D
FB
G
IP
CI
NeoCitran Hustenstiller
10 Tablet(s)
k.A.
Depottabletten: Butamirati Dihydrogenocitras 50 mg
Haleon Schweiz AG
D
FB
G
Combinations (R05DB20) 4 products
WHO-DDD
Ph
Pectolino Hustenpastillen
24 Tablet(s)
k.A.
Pastilles: 3 Active Agents
Tentan AG
E
FB
G
Pectolino Hustenpastillen N
24
k.A.
Tentan AG
E
FB
G
Ph
Herbapect
Bronchialpastillen
40
k.A.
Pastilles: 5 Active Agents
Dr. Heinz Welti AG,
Fabrikation chemisch-
pharmazeutischer
Produkte
E
FB
G
Tussipect
44 pastilles
k.A.
Pastilles: 10 Active Agents
Dr. Welti AG
D
FB
G
Morclofone (R05DB25) 1 products
WHO-DDD
IP
CI
Nitux
180 ml
k.A.
Sirup: Morclofonum 150mg / 15ml
Zambon Svizzera SA
D
FB
G
Levodropropizine (R05DB27) 2 products
WHO-DDD
IP
CI
Levocalm 30 mg / 5 ml
200 ml
k.A.
Sirup: Levodropropizinum 30mg / 5ml
Gebro Pharma AG
●
D
FB
G
IP
CI
Levocalm 30 mg / 5 ml
120 ml
k.A.
Sirup: Levodropropizinum 30mg / 5ml
Gebro Pharma AG
D
FB
G
Gefapixant (R05DB29) 2 products
WHO-DDD
IP
CI
Lyfnua
56
k.A.
Coated tablets: Gefapixantum 45 mg
MSD Merck Sharp &
Dohme AG
B
FB
G
IP
CI
Lyfnua
196
k.A.
Coated tablets: Gefapixantum 45 mg
MSD Merck Sharp &
Dohme AG
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2026
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home
